DD205-291 is a novel PROTAC-based HPK1 degrader with high selectivity and potency. DD205-291 showed a dose-dependent inhibition of SLP-76 phosphorylation and an induction of IL-2 and IFN-γ. Compared with other inhibitors, DD205-291 exhibited good efficacy and a favorable safety profile in the MC38 model. DD205-291 exhibited a low risk of cardiotoxicity and a wide safety window. DD205-291 is a promising preclinical candidate (PCC) for potential mono- and comboimmunotherapy of cancer.
MedKoo Cat#: 128047
Name: DD205-291
CAS#: N/A
Chemical Formula: C38H38ClF3N10O3
Exact Mass: 774.2769
Molecular Weight: 775.23
Elemental Analysis: C, 58.87; H, 4.94; Cl, 4.57; F, 7.35; N, 18.07; O, 6.19
The following data is based on the product molecular weight 775.23 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |